Добавил:
kiopkiopkiop18@yandex.ru t.me/Prokururor I Вовсе не секретарь, но почту проверяю Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз: Предмет: Файл:

Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_770_Библиотеки_им_академика_М_И_Перельмана

.pdf
Скачиваний:
0
Добавлен:
30.08.2026
Размер:
47 Мб
Скачать
394
https://t.me/medicina_free
Index
Dose optimisation
controllable and built-in factors
automatic tube current modulation, 52, 53 detector material, 55 iterative reconstruction, 54 matrix size, 57 overranging, 55 pitch, 57 pre-patient beam lter, 55 shielding, 55 slice thickness, 57 tube current, 52
tube voltage, 53 diagnostic reference levels, 57, 58 dose saving approach, 57 ethics, 58 justication, 51 risk estimation, 52
Double contrast barium enema (DCBE), 6, 291 Dry preparations, 99, 106 Dual energy computed tomography (DECT), 30, 47–48,
345, 347 for CRC, 217 in CTC, 348, 349 denition of, 346 dual-layer detectors, 348 dual-source CT, 347 rapid tube potential switching, 347 twin beam DECT, 347
Dual-energy X-ray absorptiometry (DXA or DEXA),
263
Dual-layer detector, 348 Dual-source CT, 347 Duke staging, 215
E
ECFs, see Extracolonic ndings (ECFs) E classication, 244, 247, 279–280, 363, 369 E2 classication, 376 Effective dose, 46, 47 Electromagnetic navigation, 39 Electronic cleansing (EC), 109, 154, 156, 168 Electronic portal, 16 Employment, 331, 332 Endocavitary therapy, 216 Endometriosis, 203 Endoscopic ultrasonography (EUS), 313, 314 Endoscopy, 235 Enterocoele, 257–259 Equilibrium dose, 48 European Society of Gastrointestinal and Abdominal
Radiology (ESGAR), 291, 297
European Society of Gastrointestinal Endoscopy
(ESGE), 291, 297
Express consent, 21 Extensive abdominal aortic calcication, 383 Extensive calcication in abdominal aorta, 266 External-beam radiation therapy, 216 External impression, 205
Extracolonic ndings (ECFs), 69, 110, 120, 241, 242,
247–256, 274 abdominal aortic calcication, 265 bone mineral density assessment, 262, 263 classication of, 243 clinical importance of, 243 and clinical outcomes at screening and diagnostic
CTC, 274 extracolonic organs and tissues, visualisation
of, 243 high clinical importance, 257 inguinal hernias, 267
complications, 268 frequency, 267 small or large bowel, 267 surgical repair procedures, 271
types of, 267 low clinical importance, 247 moderate clinical importance, 257 negative aspects of, 243 not of clinical importance, 247 vaginal air, 271 visualizing extracolonic organs and tissues, benets
of, 243 Extracolonic organs and tissues, visualisation of, 243 Extrinsic impression, 145, 146, 203, 204
F
Faecal and residual uid tagging, 2 Faecal immunochemical tests (FIT), 2 Faecalith, 228 Familial adenomatous polyposis (FAP), 213 Fatty inltration of liver, 247–256 Fatty sparing in liver, 286 Femoral hernia, 257–259, 267–271 F-18-uoro-deoxy-glucose (F-18-FDG), 324 Flat adenomas, 184 Flat, mildly lobulated interhaustral lesion, 183 Flat polyps, 182, 304, 371 Free child (FC), 13
G
Gamma-glutamyl transferase (GGT), 286 Gardners’ syndrome, 213 Gastrogran, 97, 99, 101, 102, 106, 107 Genant classication, 263 Generative adversarial network (GAN), 339 Generic justication, 51 GIST (gastrointestinal stromal tumour), 203 Guaiac faecal occult blood test (gFOBt), 64, 72
H
Haemangiomas, 203 Haemorrhagic cyst, 260–262 Haemorrhoids, 373
causes, 172 denition, 172
Index
https://t.me/medicina_free
395
external, 172 internal, 172, 173
Half-Fourier acquisition single-shot turbo spin echo
(HASTE), 316 Hardcopy brochures, 15 Haustral fold polyp, 187 Healed osteoporotic fractures, 247–256 Healthcare practitioners (HCPs), 341 Hepatic exure, 134 Hepatic steatosis, 278 Hepatitis C virus (HCV), 278 Hereditary colorectal cancer syndromes, 210, 213, 214 Hereditary non-polyposis colorectal cancer, 213 Hesselbach triangle, 267 Histology, 210 Horseshoe kidney, 247–256 Hounseld units (HU), 235, 263, 304 Human communication, 13 Hybrid imaging, 37 Hydronephrotic change right kidney, 257–259 Hyoscine-N-butylbromide (Buscopan), 85,
88, 301 Hyperplastic polyps (HPs), 198, 199, 202, 210
I
Ileocaecal valve (ICV), 129, 134–135, 137, 149 Impacted diverticulum, 223 Implied consent, 22 Incarcerated hiatus hernia, 257–259 Incarceration, 268 Incomplete optical colonoscopy, 297 Indirect inguinal hernias, 267 Inammatory polyps, 202 Inammatory pseudo polyps, 202 Information exchange, 13 Informed consent
articial intelligence, 23 autonomy, 21 clinical audit, 26 CTC radiographer, 25 duty of consent, 25 express consent, 21 good practice, 25, 26 implied consent, 22 legal aspects, 23, 24 patient information, 24 risks associated with CTC study, 24 valid consent, 22
Inguinal hernias, 227, 247–256, 267–271
complications, 268 frequency, 267 small or large bowel, 267 surgical repair procedures, 271
types of, 267 Interactive 3D medical imaging, 64 Internal haemorrhoids, 169, 172, 173, 176,
178–180, 205 Intravenous (IV) contrast, 84, 89–93 Iohexol, 2, 109
Iterative reconstruction, 34–36, 54
J
Juvenile polyp, 202
K
Kinetic energy released in matter (Kerma), 41 K-shell, 349
L
Language barriers, 12 Large calculus right kidney, 247–256 Large hiatus hernia, 257–259 Large pancreatic cyst, 260–262 Large pedunculated polyp, 187 Lasswell’s model, 13 Legal and professional requirements
clinical audits, 335 duty and standard of care, 333, 334 employment, 331, 332 framework for practice, 334, 335 professional regulation, 332, 333
Lesion, 182
size, 192 Linear polyp size, 185 Lipoma, 202, 203, 235–237, 388
anatomical sites and morphology of, 236
gender prevalence and incidence, 236
sign at optical colonoscopy, 238
symptoms and sites in colon, 236 Liquid diet, 97, 100, 101 Liver, 278, 283, 284, 286
cysts, 247–256
density, 382
fatty sparing in, 286
granuloma, 247–256 Lobulated cyst right kidney, 247–256 Lobulated polypoidal lesion, 388 Low-dose CT, 47 Low-ber diet, 97, 102 Luminal narrowing, 225 Lymph node metastasis (LNM), 386 Lynch syndrome, 213
M
Machine learning (ML), 1, 217, 263, 337, 338
reinforcement learning, 338
semi-supervised learning, 338
supervised learning, 338
unsupervised learning, 338 MAFLD, see Metabolic-associated fatty liver disease
(MAFLD)
Magnetic resonance colonography (MRC), 315
BLMRC, 315, 316
DLMRC, 316
indications for, 315
396
https://t.me/medicina_free
Index
Magnetic resonance elastography (MRE), 319 Magnetic resonance imaging (MRI), 215, 314, 315, 319
MR Colonography, 315, 316 of CRC, 319, 320 rectal MRI, 316, 317, 319
request checklist, 315 Magnetic resonance spectroscopy (MRS), 284, 319 Magnetic resonance volumetry, 319 Magnetisation transfer MR imaging, 319 Manual insufation, 103 Material decomposition, 346 Mesorectal adenopathy, 318 Messaging system, 16 Metabolic-associated fatty liver disease (MAFLD), 277,
287 alcoholic liver disease, distinguish from, 286 cryptogenic cirrhosis (CC), 281 diagnosis of, 282, 284, 286 E-classication, 279, 280 fatty sparing in liver, 286 global prevalence of, 277 incidence of, 278 measuring attenuation values, 284, 286 metabolic syndrome, 280, 281
clinical outcomes, 281 and non-alcoholic steatohepatitis (NASH), 280 opportunistic screening of, 277 patient management, 286 serum liver enzyme tests, 286
Metabolic-associated steatohepatitis (MASH), 280 Metabolic syndrome, 280, 281
clinical outcomes, 281 features, 281
Metal artefacts, 69 Metastatic rectosigmoid cancer, 327 Microsatellite instability (MS1), 210, 211 Mild calcication in abdominal aorta, 266 Milk of calcium bile, 247–256 Moderate calcication in abdominal aorta, 266 Moderate hiatus hernia, 247–256 Mucosal’ polyp, 202 Multi-detector CT (MDCT), 268 Multi-energy CT imaging, 347, 350 Multiple calcied gallstones, 247–256 Multiple detector arrays, 36, 37 Multiple diverticula, 223 Multiple gallstones with gas, 247–256 Multiple scan average dose (MSAD), 43, 44
N
Naked fat sign, 238 Negligence, 333 Neoplastic intramural submucosal lesions, 203 Neural networks (NNs), 339 Non-afne transformations, 38 Non-alcoholic fatty liver disease (NAFDL), 277
of alcohol consumption, 281, 282
Non-alcoholic steatohepatitis (NASH), 280 Non-neoplastic mucosal lesions, 202
Nonneoplastic submucosal lesions, 203 Non-polypoidal lesion, 371 Normal adrenal glands, 247–256 Normal colon, 130 Nuclear medicine imaging in colon cancer, 323, 324
articial intelligence (AI) in PET-CT, 327 clinical audits for good practice, 328 PET study, 325
for CRC Patients, 327
PET-CT, 324, 325
interpretation, 325, 327
radiopharmaceutical, 324
Nuclear medicine imaging modalities (PET or SPECT)
image radiotracers, 38
Nurturing parent (NP), 13
O
Omnipaque, 109, 118 Opportunistic screening HU values, 310 Optical colonoscopy (OC), 2, 3, 5, 210, 230, 291, 375
incomplete and failed, reason for, 292, 297
lipoma sign at, 238 Optimisation, 51–52, 57–58 Osteopenia, 263–265 Overranging, 55, 56
P
Pancreatic mass, 260–262 Patent ileocaecal valve, 381 Patient-centered communication
audiovisual instructional material, 15
CTC examinations, 16
denotative and connotative meanings, 15
patient feedback, 16
readability
imaging reports, 16 informed consent forms, 16 instructions, 16
signs and symbols and codes, 14, 15 Patient-centered concepts, 310 Patient group directive (PGD), 354 Pedunculated lipoma, 388 Pedunculated polyps, 117, 121, 182, 183, 187, 304 Pelvic radiotherapy, 216 Pericardium, 245–246 Pericolonic inltration, 229 Photoelectric effect, 217, 345, 346, 349 Photon counting CT, 345, 349, 350 Picolax®, 67, 68 Pitch, 57 Plasma glucose level, 324 Polymethyl methacrylate (PMMA) phantom, 42 Polypectomy, 3, 215 Polypoid structures, 182 Polypoidal lesion, 115, 116, 211, 237 Polyps, 209, 302, 304, 305, 374
adenomatous polyps, 195
advanced adenoma, 194, 195
Index
https://t.me/medicina_free
397
articial intelligence, 205 carpet lesions, 198 C classication, 192 clinical signicance, 192 colonic classications, 192 denition, 182 diminutive lesion, 192 dual-energy CT, 205 hyperplastic polyps, 198 measurements, 184, 185 morphology, 156, 182, 184 neoplastic and nonneoplastic causes, 203 non-neoplastic mucosal lesions, 202 prevalence range, 193 serrated lesions of the colon and rectum, 199, 200 small lesions (6-9 mm), 193, 194 submucosal lesion, 202
neoplastic intramural, 203
nonneoplastic, 203 surveillance period, 193 tubular adenomas, 196 tubulovillous adenomas, 197 typical features, 187, 196 villous adenomas, 197
Positron emission tomography–computed tomography
(PET/CT), 214, 327 articial intelligence (AI) in, 327 colonography, 38 interpretation, 325, 327 patient preparation, 324, 325
Positron emission tomography (PET) study, 324, 325
for CRC Patients, 327
Posterior descending coronary artery, 245–256 Postpolypectomy coagulation syndrome, 3 Postpolypectomy distension syndrome, 3 Precancerous colorectal lesions, 199 Precision medicine, 339 Precursor lesion, 210 Proximal carcinoid tumours, 203 Punctate calcication, 372 Pyelonephritic scarring left kidney, 247–256
Q
Quantity, 30
R
Radiation therapy, 216
AI applications in, 217, 218
Radiation units, 41, 42 Radioembolisation, 216 Radiogenomics, 320 Radiographers, 332, 335 Radiography, AI on, 339, 340 Radioisotopes decay, 323 Radiology imaging, 297 Radiomics, 320, 328 Rapid kV switching, 348 Rapid tube potential switching, 347 Ray, 29–33, 35
Readability
imaging reports, 16 informed consent forms, 16
instructions, 16 Reasonableness, 331 Rectal cancer, 176–177 Rectal magnetic resonance imaging, 316, 317, 319 Rectal polyp, 176 Rectal tube position, 169, 170 Rectal varices, 178, 180 Rectosigmoid, 131 Rectovaginal stula, 272–273 Rectum, 130, 374, 378, 387
anatomy, 172 Redundancy of colon segments, 292 Redundant transverse colon, 292 Reinforcement learning, 338 Response evaluation criteria in solid tumors (RECIST),
319
Retained faecal matter, 153–154
S
Semi-annular carcinoma, 211 Semi-supervised learning, 338 Serrated lesions of the colon and rectum, 199, 200 Serrated polyp-carcinoma pathway sequence, 210, 211 Serum liver enzyme tests, 286 Sessile lesion, 196 Sessile polyps, 182, 183, 187, 304 Sessile serrated polyp (SSP), 199, 200, 211 Shannon and Weaver model, 13 Sigmoid colon, 211, 227, 228, 232, 292, 375, 379 Sigmoid diverticular disease, 156 Single detector arrays, 36, 37 Sliding window technique, 39 Slip-ring technology, 37 Small bowel hernias, 268–271 Small hiatus hernia, 247–256 Small pericardial effusion, 247–256 Small polyps, 184, 187, 193, 196 Small sessile polyp, 187 Sophisticated computer graphics software, 65 Spleen, 278, 284, 286, 376 Splenomegaly, 260–262 Spondylolisthesis, 205, 247–256, 383 Steatosis, 277 ‘Straight-to-test’ (STT), 64 Strangulation, 268 Streak artefacts, 378 Submucosal lesions, 202, 203
neoplastic intramural, 203
nonneoplastic, 203 Supervised learning, 338 Suprep (OSS®), 99 Surface rendering, 37
T
Tagging agents, 97, 98, 153 Tagging solutions, 152
398
https://t.me/medicina_free
Index
Tensor deep stack networks (TDSNs), 339 Tenting’ sign, 238 Thick fascia, 230 Three-dimensional (3D) data set, 36 3D y-through, 370 3D-2D approach, 301, 304 3D virtual y-through, 292 Tomographic reconstruction, 31–36 Traditional serrated adenoma (TSA), 199, 200 Transactional analysis (TA), 13 Transrectal ultrasound (TRUS), 314, 319 Transverse colon, 133 Traps and artefacts
anatomical locations and structures, 156 beam hardening artefacts, 160 bowel preparation, 152 catheter, position of, 158, 160 ‘dense waterfall’ sign, 160 electronic cleansing, 154, 156 extrinsic impressions, 157 ingested artefacts, 160 movement artefacts, 160 mucus strand, 161 polyps, 156 sigmoid diverticular disease, 156 tagging solutions, 152, 153
Tampon and vaginal pessary, 161 TRUS, see Transrectal ultrasound (TRUS) Tube current, 52
modulation, 53 Tube voltage, 53 Tubular adenomas, 196, 374 Tubulovillous adenomas, 183, 197 Tumour, nodes, metastases (TNM) staging system, 214,
313, 319, 323, 386
Twin beam DECT, 347
U
Ultrasound, 38 Ultrasound elastography (USE), 314 Umbilical hernia, 247–256, 296, 378 Unsupervised learning, 338 Urachal remnant, 247–256
V
Vaginal air, 271–274 Vaginal tampons, 385 Valid consent, 21, 22 Valves of Houston, 177, 178 V3D Viatronix, 305 Verbal and nonverbal communication, 13, 14 Viatronix V3D system, 123, 185, 306 Villous adenomas, 197 Vimap 3-way connection catheter, 170 Virtual colonoscopy (VC), 2, 319
W
Warping techniques, 39 Watch and wait approach, 320 Wet preparation, 99, 117 World Health Organisation (WHO), 209, 281
X
X-ray attenuation, 346 X-ray beam, 41, 42 X-ray interaction mechanisms
Compton scatter, 345 photoelectric effect, 345, 346
X-ray photon, 29